Eltrombopag in Good’s Syndrome [PDF]
Case Reports in Hematology, 2014 Good’s syndrome is a rare acquired immunodeficiency associated with thymoma. Eltrombopag is a thrombopoietin receptor agonist and has been shown to be a valuable supplement to the treatment of several types of refractory cytopenias.
Håvard Anton Kristiansen +3 more
doaj +6 more sources
COVID-19 in patients with thymic epithelial tumors with or without Good’s syndrome: a single-center retrospective study [PDF]
BMC CancerIntroduction Thymic epithelial tumors (TETs) are rare neoplasms often associated with immune-related disorders. Patients with Good’s syndrome (GS), an adult-acquired TET-related immunodeficiency, are at a high risk of mortality due to infectious diseases.
Erica Pietroluongo +25 more
doaj +4 more sources
COVID-19 in a patient with Good's syndrome and in 13 patients with common variable immunodeficiency [PDF]
Clinical Immunology Communications, 2021 Antibody deficiencies constitute the majority of primary immunodeficiencies in adults. These patients have a well-established increased risk of bacterial infections but there is a lack of knowledge regarding the relative risks upon contracting COVID-19 ...
Hannes Lindahl +2 more
doaj +2 more sources
A Case of Severe COVID-19 in a Patient with Good's Syndrome [PDF]
European Journal of Case Reports in Internal Medicine, 2021 Good’s syndrome is a rare adult-onset combined immunodeficiency. The association of hypogammaglobulinaemia with a history of recurrent infectious or autoimmune manifestations in a middle-aged patient with evidence of a mediastinal mass should lead to the
Maria Duarte +4 more
doaj +2 more sources
Good's Syndrome Presenting With Weaning Failure From Ventilation and Myasthenia Gravis in a Post‐Thymectomy Patient [PDF]
Respirology Case ReportsGood's syndrome is a rare adult‐onset immunodeficiency associated with thymoma, hypogammaglobulinemia, and cellular immune dysfunction. We report a man in his 50s with a prior thymectomy who presented with recurrent pneumonia, chronic diarrhoea, and ...
Asmita Anilkumar Mehta +4 more
doaj +2 more sources
Good's syndrome and recurrent leishmaniasis: A case report and review of literature [PDF]
Heliyon, 2020 We report the case of a 56-year-old Caucasian male affected by thymoma and myasthenia gravis that developed recurrent visceral leishmaniasis 11 years after thymectomy.
Manlio Tolomeo +5 more
doaj +2 more sources
Good's syndrome presenting with CMV pneumonitis and oesophageal candidiasis: A case report [PDF]
Respirology Case Reports, 2022 Good's syndrome is an acquired combined T‐ and B‐cell immunodeficiencies and patients are prone to opportunistic infections. The diagnosis is based on a characteristic immunoglobulin and lymphocyte subset profile, with clinical features of thymoma ...
Chin Tong Kwok, Yiu Cheong Yeung
doaj +2 more sources
Insights from a Case of Good’s Syndrome (Immunodeficiency with Thymoma) [PDF]
Biomedicines, 2023 Immunodeficiency with thymoma was described by R.A. Good in 1954 and is also named after him. The syndrome is characterized by hypogammaglobulinemia associated with thymoma and recurrent infections, bacterial but also viral, fungal and parasitic ...
Roberto Paganelli +6 more
doaj +2 more sources
Good's syndrome with diffuse panbronchiolitis as the prominent manifestation: A case and literature review [PDF]
Respirology Case Reports, 2021 Good's syndrome (GS) is characterized by thymoma combined with adult‐onset immunodeficiency. Diffuse panbronchiolitis (DPB) is a chronic inflammatory airway disease, which predominantly affects East Asians.
Tian Luo +6 more
doaj +2 more sources
Case report: Persistent hypogammaglobulinemia in thymoma-associated myasthenia gravis: the impact of rituximab or Good's syndrome? [PDF]
Frontiers in Neurology, 2023 IntroductionRituximab (RTX) showed good efficacy and safety for patients with myasthenia gravis. However, the percentage of peripheral CD20+ B cell may be absent for years after low dose of RTX treatment.
Jingru Ren +7 more
doaj +2 more sources